1 US FDA approved drugs website, https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020452s005lbl.pdf
2 US FDA approved drugs website, https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018057s083lbl.pdf
3 Adams M et al., Acta Oncol (1989) 28(1):57-60, https://www.ncbi.nlm.nih.gov/pubmed/2650722
4 Mangioni C et al., J Natl Cancer Inst (1989) 81(19):1464-71, https://www.ncbi.nlm.nih.gov/pubmed/2674459
5 Rose PG et al., Gynecol Oncol (2003) 88(2):130-5, https://www.ncbi.nlm.nih.gov/pubmed/12586591
6 US FDA approved drugs website, https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020262s051lbl.pdf
7 Eishenhauer EA et al., J Clin Oncol (1994) 12(12):2654-66, https://www.ncbi.nlm.nih.gov/pubmed/7989941
8 ten Bokkel Huinink W et al., J Clin Oncol (1997) 15(6):2183-93, https://www.ncbi.nlm.nih.gov/pubmed/9196130
9 Rose PG et al., J Clin Oncol (1998) 16(2):405-10, https://www.ncbi.nlm.nih.gov/pubmed/9469322
10 US FDA approved drugs website, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020509s081lbl.pdf
11 US FDA approved drugs website, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/050718s051lbl.pdf
12 Gordon AN et al., J Clin Oncol (2001) 19(14):3312-22, https://www.ncbi.nlm.nih.gov/pubmed/11454878
13 US FDA approved drugs website, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020671s023lbl.pdf
14 Safra T et al., Gynecol Oncol (2007) 105: 205-210, https://www.ncbi.nlm.nih.gov/pubmed/17239430
15 Abushahin F et al. Gynecol Oncol (2008) 108: 53-57, https://www.ncbi.nlm.nih.gov/pubmed/17904208
16 Burger RA et al., J Clin Oncol (2007) 25(33):5165-71, https://www.ncbi.nlm.nih.gov/pubmed/18024863
17 Cannistra SA et al., J Clin Oncol (2007) 25(33):5180-6, https://www.ncbi.nlm.nih.gov/pubmed/18024865
18 US FDA approved drugs website, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022465s024s025lbl.pdf
19 US FDA approved drugs website, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s014lbl.pdf
20 US FDA approved drugs website, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209115s003lbl.pdf
21 US FDA approved drugs website, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208447s015s017lbledt.pdf
22 US FDA approved drugs website, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125514s045lbl.pdf
23 Le DT et al., NEJM (2015) 372(26):2509-20, https://www.ncbi.nlm.nih.gov/pubmed/26028255
24 US FDA approved drugs website, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204114s014lbl.pdf
25 Gershenson DM et al., Ann Oncol (2019) 30(Suppl_5): abstr LBA 61, https://oncologypro.esmo.org/meeting-resources/esmo-2019-congress/A-Randomized-Phase-II-III-Study-to-Assess-the-Efficacy-of-Trametinib-in-Patients-with-Recurrent-or-Progressive-Low-Grade-Serous-Ovarian-or-Peritoneal-Cancer